Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathway
- 30 November 1982
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 50 (5), 1087-1089
- https://doi.org/10.1016/0002-9149(82)90422-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Death after ajmaline administrationThe American Journal of Cardiology, 1980
- Use of ajmaline in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathwayThe American Journal of Cardiology, 1980
- Ventricular Fibrillation in the Wolff-Parkinson-White SyndromeNew England Journal of Medicine, 1979
- Value and limitations of programmed electrical stimulation of the heart in the study and treatment of tachycardias.Circulation, 1978
- Atrial fibrillation in the preexcitation syndromeThe American Journal of Cardiology, 1977
- Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome.Circulation, 1977
- The Wolff-Parkinson-White syndrome: Pharmacologic effects of procaine amideAmerican Heart Journal, 1975
- Wolff-Parkinson-White syndrome and atrial fibrillation: Relation between refractory period of accessory pathway and ventricular rate during atrial fibrillationThe American Journal of Cardiology, 1974
- Effect of Procaine Amide, Quinidine, and Ajmaline in the Wolff-Parkinson-White SyndromeCirculation, 1974
- Factors regulating ventricular rates during atrial flutter and fibrillation in pre-excitation (Wolff-Parkinson-White) syndrome.Heart, 1973